Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction

Brad Moriyama, Oluwaseun Falade-Nwulia, Janice Leung, Scott R. Penzak, Caroline Jjingo, Xuan Huang, Stacey A. Henning, Wyndham H. Wilson, Thomas J. Walsh

Research output: Contribution to journalLetterpeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)e877-e879
Issue number6
StatePublished - Nov 2011

Cite this